At the last check on Thursday, Infinity Pharmaceuticals Inc.’s (NASDAQ:INFI) stock traded at $0.11. The average number of shares traded per day over the past five days has been 2,694,025 shares. 3 times new highs have been achieved over the past 5 days, with a $0.0052 gain in that time frame. In the last twenty days, the average volume was 8,383,681, while in the previous 50 days, it was 3,851,334.
Since last month, INFI stock retreated -44.68%. Shares of the company fell to $0.0850 on 08/16/23, the lowest level in the past month. A 52-week high of $1.76 was reached on 01/18/23 after having rallying from a 52-week low of $0.09. Since the beginning of this year, INFI’s stock price has dropped by -79.57% or -$0.4408, and marked a new high 7 times. However, the stock has declined by -93.56% since its 52-week high.
Financial Health
In the three months ended March 30, Infinity Pharmaceuticals Inc.’s quick ratio stood at 1.70, while its current ratio was 1.70, showing that the company is able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is 39.70% percent. Based on annual data, INFI earned $47.44 million in gross profit and brought in $2.59 million in revenue.
According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. INFI’s revenue fell -18.97% to $0.73 million during the quarter, while net income inched up to $0.58 million. While analysts expected Infinity Pharmaceuticals Inc. to report -$0.1 quarterly earnings, the actual figure was -$0.12 per share. During the quarter, the company generated -$10.01 million in EBITDA. The liabilities of Infinity Pharmaceuticals Inc. were 58.64 million at the end of its most recent quarter ended March 30. The value of shareholders’ equity is $90.76 million.
Technical Picture
This quick technical analysis looks at Infinity Pharmaceuticals Inc.’s (INFI) price momentum. With a historical volatility rate of 297.28%, the RSI 9-day stood at 45.91% on 16 August.
With respect to its five-day moving average, the current Infinity Pharmaceuticals Inc. price is up by +4.77% percent or $0.0052. At present, INFI shares trade -42.90% below its 20-day simple moving average and -42.90% percent below its 100-day simple moving average. However, the stock is currently trading approximately -39.06% below its SMA50 and -90.79% below its SMA200.
Stochastic coefficient K was 18.85% and Stochastic coefficient D was 14.15%, while ATR was 0.0225. Given the Stochastic reading of 28.83% for the 14-day period, the RSI (14) reading has been calculated as 43.22%.
Analyst Ratings
H.C. Wainwright launched its rating on Infinity Pharmaceuticals Inc. (NASDAQ: INFI) to a Buy in a note to investors on October 18, 2021. Infinity Pharmaceuticals Inc. (INFI) has been rated Hold by analysts. According to 0 brokerage firms, INFI is a sell, and 1 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Infinity Pharmaceuticals Inc. stock as buy, with 0 recommending it as overweight.
With a median target price of $0.30, the current consensus forecast for the stock is $0.30 – $0.30. Based on these forecasts, analysts predict Infinity Pharmaceuticals Inc. (INFI) will achieve an average price target of $0.30.
